ClinicalThought


Share

Program Content

Activities

  • MRD and BTKi Resistance in CLL
    CLL Management: Testing for MRD and BTK Mutations
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 05, 2024

    Expires: November 04, 2025

Faculty

cover img faculity

Jennifer R. Brown, MD, PhD

Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
CLL Center Director and Institute Physician
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca

AstraZeneca